the Pharmaceutical companies community of South Africa

Aspen business in licensing deal with GSK

Thu, 24 Jul 2008 09:00:00 +0200

JSE listed Aspen Pharmacare Holdings Limited (Apn) has announced that it has entered into licensing and supply agreements with leading multinational pharmaceutical corporation, GlaxoSmithKline (“GSK”). Read full story... | Send to a friend

Recruit patients quick with a click

Tue, 22 Jul 2008 07:19:00 +0200

The clinical drug trials required to ensure the next Avastin, Viagra or Lipitor actually make it to market are often lasting longer than expected. In fact, 90% of trials are delayed, and the majority of these delays are attributed to patient recruitment problems, perhaps as patient recruitment takes longer than any other step of the trial and the public perception of the clinical trial process and pharmaceutical industry on the whole is largely very negative. Read full story... | Send to a friend

DNA labelling for drug security?

Mon, 14 Jul 2008 07:43:00 +0200

German logistics firm Movianto GmbH has developed what it considers to be the most effective protection against the infiltration of counterfeit drugs into the supply chain: DNA labelling. In a statement, the firm noted that the proportion of counterfeit products has recently been reported by the European Commission to be rapidly increasing. Read full story... | Send to a friend

Aspen win tender for antiretrovirals for Department of Health

Fri, 27 Jun 2008 08:44:00 +0200

Antiretroviral tender results Read full story... | Send to a friend

Pfizer completes acquisition of Encysive Pharmaceuticals Inc

Tue, 24 Jun 2008 12:40:00 +0200

Pfizer Inc (NYSE:PFE) recently announced that it has completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ:ENCY) through a merger of Pfizer's wholly-owned subsidiary, Explorer Acquisition Corp., with and into Encysive. Encysive is now a wholly-owned subsidiary of Pfizer. Read full story... | Send to a friend

Cipla secures alliance with X/Procure®

Mon, 16 Jun 2008 11:20:00 +0200

Cipla Medpro believes that all South Africans should have access to world class, but affordable medicines, lessening the burden of high drug costs and bettering the health and lives of all South Africans. Read full story... | Send to a friend

Pharmacovigilance in the spotlight

Thu, 05 Jun 2008 06:27:00 +0200

Predictive and proactive pharmacovigilance paves the road for drug safety solutions. Read full story... | Send to a friend

Pharma moving to more restricted drug distribution, in attempt to guard drug supply chain

Thu, 15 May 2008 06:10:00 +0200

Ideally, drug supply should be a simple and transparent chain that connects the manufacturer and patient in as few steps as possible. However, in practice it can be a highly circuitous one that includes several intermediaries before reaching a pharmacy. Notwithstanding the possibility that drug integrity can be compromised in transit, complex supply chains risk counterfeit drug entry. Read full story... | Send to a friend

Leading ED treatment celebrates five years in South Africa

Thu, 24 Apr 2008 08:42:00 +0200

Lilly's treatment for erectile dysfunction still market leader Read full story... | Send to a friend

‘Conservative' pharma slow to take advantage of online marketing opportunities

Wed, 23 Apr 2008 08:35:00 +0200

While the internet has altered the landscape in the retail sector and revolutionised the airline industry, pharmaceutical companies have been slow to take advantage of the marketing opportunities offered by the internet. However, the same cannot be said of customers, who are increasingly using the web to source information. Read full story... | Send to a friend